Carl Dambkowski

Companies

• Oruka Therapeutics, Inc.Board member Sep 6, 2024 to now¹
• Apogee Therapeutics, Inc.Chief Medical Officer Jul 13, 2023 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• OTOruka Therapeutics, Inc. ORKA38,743 shares³$2.9M at $73.87Jun 12, 2026
• ATApogee Therapeutics, Inc.0 shares⁴Sep 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 3, 2026Returned to company 167,123 shares of Apogee Therapeutics, Inc.⁴
• Sep 2, 2026Returned to company 1,375 shares at $135.06 of Apogee Therapeutics, Inc.⁴
• Aug 5, 2026Sold 5,500 shares at $134.17 of Apogee Therapeutics, Inc.⁵
• Aug 5, 2026Exercised options 4,125 shares at $22.86 of Apogee Therapeutics, Inc.⁵
• Jul 14, 2026Gift 8,000 shares of Apogee Therapeutics, Inc.⁶
• Jul 1, 2026Sold 5,500 shares at $132.74 of Apogee Therapeutics, Inc.⁷
• Jul 1, 2026Exercised options 4,125 shares at $22.86 of Apogee Therapeutics, Inc.⁷
• Jun 22, 2026Sold 26,400 shares at $132.60 of Apogee Therapeutics, Inc.⁸
• Jun 12, 2026Sold 12,583 shares at $70.11 of Oruka Therapeutics, Inc.³
• Jun 11, 2026Sold 22,417 shares at $70.13 of Oruka Therapeutics, Inc.³
• Jun 3, 2026Sold 5,500 shares at $78.71 of Apogee Therapeutics, Inc.⁹
• Jun 3, 2026Exercised options 4,125 shares at $22.86 of Apogee Therapeutics, Inc.⁹
• May 21, 2026Sold 13,235 shares at $59.97 of Oruka Therapeutics, Inc.¹⁰
• May 21, 2026Sold 53,447 shares at $59.10 of Oruka Therapeutics, Inc.¹⁰
• May 21, 2026Sold 38,318 shares at $58.43 of Oruka Therapeutics, Inc.¹⁰
• May 21, 2026Exercised options 11,667 shares at $11.77 of Oruka Therapeutics, Inc.¹⁰
• May 21, 2026Exercised options 11,904 shares at $7.80 of Oruka Therapeutics, Inc.¹⁰
• May 21, 2026Exercised options 38,689 shares at $6.84 of Oruka Therapeutics, Inc.¹⁰
• May 6, 2026Sold 1,800 shares at $84.60 of Apogee Therapeutics, Inc.¹¹
• May 6, 2026Sold 3,700 shares at $83.92 of Apogee Therapeutics, Inc.¹¹
• May 6, 2026Exercised options 4,125 shares at $22.86 of Apogee Therapeutics, Inc.¹¹
• Apr 1, 2026Sold 100 shares at $85.89 of Apogee Therapeutics, Inc.¹²
• Apr 1, 2026Sold 2,702 shares at $85.33 of Apogee Therapeutics, Inc.¹²
• Apr 1, 2026Sold 2,698 shares at $84.31 of Apogee Therapeutics, Inc.¹²
• Apr 1, 2026Exercised options 4,125 shares at $22.86 of Apogee Therapeutics, Inc.¹²